www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Companies

Guilin at forefront in battle against malaria

By Wang Hongyi (China Daily) Updated: 2015-11-09 09:47

Since 2000, global mortality rates among malaria patients have dropped by 47 percent. In Africa, the rate has come down by 54 percent for adults and 58 percent for children.

GPSC has played an important role, along with major global pharmaceutical companies such as Novartis in Switzerland and Sanofi-Aventis in France, in fighting malaria.

The Chinese company was at the forefront in developing the innovative artesunate vaccine, Artsun, the first of its kind, to replace quinine injections. The WHO has compared it to the "gold standard" in the battle against malaria.

Artsun is now registered in more than 30 countries and regions and has a 90 percent market share in treating servere malaria.

During the past three years, GPSC has supplied 23.8 million units of the vaccine globally, saving more than 3.4 million people from the scourge of malaria.

"This is an innovative drug that was developed in China," Guo Guangchang, chairman of Fosun Group, said.

During the past decade, 13 anti-malaria drugs developed by GPSC have been approved by the WHO, including three which are injected and 10 in oral tablets.

The company's products account for 80 percent of China's anti-malaria drug exports.

In the first three quarters of this year, Fosun Pharmaceutical, which includes GPSC, reported revenue of 9 billion yuan ($1.41 billion), a rise of 4.76 percent compared to the same period in 2014.

Further financial details have yet to be released. The company's products include metabolism and digestive system drugs, and vaccines, as well as GPSC's brands.

"At present, Guilin Pharma is building a new manufacturing site which will comply with (international) standards," GPSC said.

"In future, we will have a production capacity of over 15 billion tablets/capsules per year to meet the needs of both domestic and global markets." the company added.

Fosun Pharmaceutical also plans to expand its research and development program by working alongside institutions and other organizations.

"There should be more cooperation with research institutes and organizations," Chen Qiyu, chairman of Fosun Pharmaceutical, said.

"This would help create a much larger platform, allowing us to do a better job globally."

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 亚洲午夜精品久久久久久抢 | 99视频精品免视3 | a欧美在线 | 99热播 | 久久91在线 | 日本美女高清在线观看免费 | 中文字幕乱 | 亚洲成人偷拍自拍 | 国产一级不卡毛片 | 成年人看的毛片 | 欧美a毛片 | 日韩性片 | 91成人精品 | 一区二区三区四区五区六区 | 特级毛片免费视频播放 | 女人扒开腿让男人捅啪啪 | 亚洲精品在线视频 | 中文在线com | 国产精品理论 | 男女视频在线观看 | 成人女人a毛片在线看 | 日本一级毛片中文字幕 | 91精品视频免费 | 在线免费观看亚洲 | 欧美成人性色生活片天天看 | 久久手机在线视频 | 日本不卡免费高清一级视频 | 日韩成人小视频 | 欧美综合亚洲 | 91在线成人| 免费观看欧美一级特黄 | 国内精品伊人久久久久妇 | 精品国产一二三区 | 天空在线观看免费完整 | 国产欧美日韩高清专区手机版 | 成人欧美一区二区三区 | 国产精品久久久久久久专区 | 日韩亚洲国产综合久久久 | 国产精品亚洲二线在线播放 | 成人毛片免费观看视频在线 | 亚洲一区二区三 |